benzoapyrene phase 2 glutathione s transferase 3 Biotransformation pathway of benzo( a )pyrene (BaP) Benzo[a]pyrene (3,4-Benzopyrene) | Noxious Pollutant
Description
Initial research on DSIP has hypothesized that its potential impact on sleep may have downstream impacts as a cancer cell-mitigating agent
![benzoapyrene phase 2 glutathione s transferase 3 Biotransformation pathway of benzo( a )pyrene (BaP) Benzo[a]pyrene (3,4-Benzopyrene) | Noxious Pollutant](https://file.medchemexpress.com/product_pic/hy-107377.gif)
Michelle Ellern Dr
![benzoapyrene phase 2 glutathione s transferase 3 Biotransformation pathway of benzo( a )pyrene (BaP) Benzo[a]pyrene (3,4-Benzopyrene) | Noxious Pollutant](https://ars.els-cdn.com/content/image/1-s2.0-S016041202100670X-gr1.jpg)
Elle apporte 1500 mg, voire 2000 mg selon les versions, de L-Glutathion Rduit par jour, cest--dire la forme active directement utilisable par lorganisme
![benzoapyrene phase 2 glutathione s transferase 3 Biotransformation pathway of benzo( a )pyrene (BaP) Benzo[a]pyrene (3,4-Benzopyrene) | Noxious Pollutant](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10565-020-09579-5/MediaObjects/10565_2020_9579_Figa_HTML.png)
In contrast, the intranasal route enhanced the distribution of insulin to the olfactory bulb with minimal systemic exposure of insulin
![benzoapyrene phase 2 glutathione s transferase 3 Biotransformation pathway of benzo( a )pyrene (BaP) Benzo[a]pyrene (3,4-Benzopyrene) | Noxious Pollutant](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a2b/8878767/8919f275ff5e/molecules-27-01379-g002.jpg)
![benzoapyrene phase 2 glutathione s transferase 3 Biotransformation pathway of benzo( a )pyrene (BaP) Benzo[a]pyrene (3,4-Benzopyrene) | Noxious Pollutant](https://www.researchgate.net/publication/306423566/figure/fig14/AS:398612568789008@1472048050941/Metabolic-activation-of-benzoapyrene-into-a-carcinogenic-metabolite-and-detoxification.png)